Ensign Peak Advisors, Inc Landos Biopharma, Inc. Transaction History

Ensign Peak Advisors, Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$4.7 - $15.0 $587,500 - $1.88 Million	-125,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$9.47 - $16.26 $1.18 Million - $2.03 Million	125,000 New	125,000 $1.2 Million

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.